Editing Niacin (section)

====Diabetes====
The high doses of niacin used to treat [[hyperlipidemia]] have been shown to elevate [[blood sugar|fasting blood glucose]] in people with type 2 [[diabetes mellitus|diabetes]].<ref name=Ong2014>{{cite journal |vauthors=Ong KL, Barter PJ, Waters DD |title=Cardiovascular drugs that increase the risk of new-onset diabetes |journal=Am. Heart J. |volume=167 |issue=4 |pages=421–8 |date=April 2014 |pmid=24655688 |doi=10.1016/j.ahj.2013.12.025 |s2cid=205306912 |url=http://www.escholarship.org/uc/item/6gd606b1 |access-date=27 June 2020 |archive-date=28 June 2020 |archive-url=https://web.archive.org/web/20200628180527/https://escholarship.org/uc/item/6gd606b1 |url-status=live |hdl=1959.4/unsworks_43825 |hdl-access=free }}</ref> Long-term niacin therapy was also associated with an increase in the risk of new-onset type 2 diabetes.<ref name=Ong2014 /><ref name=Goldie2016>{{cite journal | vauthors = Goldie C, Taylor AJ, Nguyen P, McCoy C, Zhao XQ, Preiss D | title = Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials | journal = Heart | volume = 102 | issue = 3 | pages = 198–203 | date = February 2016 | pmid = 26370223 | pmc = 4752613 | doi = 10.1136/heartjnl-2015-308055 }}</ref>